| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |